accountwould look to make a deal or two to keep pace with its main rivals, McKesson (MCK) and Cardinal Health (CAH). That doesn't appear to be the case, at least for now. During a Dec. 16 investor-day conference, company officials said they had no...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to No. 3 Drug Distributor Takes Cautious View On Acquisitions
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account